Partner with Oatmeal Health

Lung cancer screening infrastructure for every stakeholder

We build the AI and the network. You bring the mission, the patients, or the funding. Five ways organizations work with us to close the lung screening gap.

Health systems & FQHCs
Find every eligible patient in your panel

LungIQ identifies screening-eligible patients from clinical notes, no EHR integration required. Works from a CSV or flat file export. Tracks outreach, scheduling, and HEDIS completion automatically.

  • No EHR integration required, works from CSV export
  • HEDIS and quality metric tracking built in
  • Consortium model connects FQHCs to imaging partners
Learn more for FQHCs
Imaging centers
AI-assisted reads and referred scan volume

LungAI provides a 0-100 malignancy probability score for every nodule, delivered inside your existing CADe viewer. The consortium model drives referred scan volume from community health centers in your region.

  • LungAI scores inside your existing CADe workflow
  • Referred LDCT volume from FQHC consortium
  • CPT 0721T reimbursement pathway following FDA clearance
Learn more for imaging centers
Nonprofits & foundations
Turn grant funding into measurable screening completions

Embed LungIQ directly into your community health partners. Every dollar spent on screening is tracked from patient identification through completed LDCT, giving you the outcomes data grant compliance requires.

  • Outcomes reporting for grant compliance and renewals
  • Proven reach into Black, Hispanic, and rural communities
  • No technology burden on your grantee sites
Government & public health
Population-level screening across FQHC networks

State and local health departments deploy LungIQ across FQHC networks to drive lung cancer screening rates for Medicaid and underinsured populations. Population-level dashboards track screening completion by region, demographics, and site.

  • Population-level dashboards and screening rate reporting
  • HIPAA compliant data infrastructure, BAA ready
  • Proven model for Medicaid and underinsured populations
Pharma & biotech
34M+ patients across a nationwide FQHC network

Access diverse, underserved patient populations for clinical trial enrollment, real-world evidence studies, and FDA diversity action plan compliance. Our FQHC network spans community health centers across the country with verified demographic data.

  • 34M+ patients across diverse, underserved communities
  • Clinical trial enrollment and real-world evidence data
  • Verified demographics for FDA diversity action plan submissions
34M+
Patients in FQHC network
1,400+
FQHC sites nationwide
63%
Racial/ethnic minority patients
Ready to partner?

Tell us about your organization and we'll show you how LungIQ fits your screening goals.

Get in touch